
The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight reduction, as experts warn of side effects.
The U.S. Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.
The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and lo… [+4093 chars]









